This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Metastases, Neoplasm
Interventions: DRUG: ZD6474
Sponsor: Genzyme, a Sanofi Company